Mendonça André de Oliveira, Zuelke Kurt Allen, Kahl-Mcdonagh Melissa M, Mafra Claudio
National Veterinary Laboratory-LFDA/SP-Ministry of Agriculture (MAPA), Campinas, SP, Brazil.
Texas A&M Global Health Research Complex (GHRC), College Station, TX, USA.
Appl Biosaf. 2024 Mar 1;29(1):45-56. doi: 10.1089/apb.2023.0005. Epub 2024 Feb 28.
Although the United States and other countries have implemented comprehensive legislation, regulations, and policies to support biosafety and biosecurity of high- and maximum-containment laboratories, Brazil's legislation has notable gaps and inconsistencies.
To evaluate the Brazilian approach to ensuring nationwide biosafety and biosecurity oversight and governance of high- and maximum-containment laboratories.
A systematic gap analysis was conducted to compare Brazilian biosafety and biosecurity legislation, regulations, and policies with their international counterparts, with a particular focus on the oversight and governance of high- and maximum-containment laboratories.
We found that Brazilian biosafety and biosecurity legislation, regulations, and policies have relevant gaps. Governance and regulatory oversight of Brazil's high- and maximum-containment laboratories are decentralized with variable levels of adherence to commonly accepted global biosafety and biosecurity compliance standards. These findings represent a limitation not only to governance but also to the preparedness to face current and future challenges related to emergent infectious diseases in Brazil. Enhancing the Brazilian legal framework on laboratory biosafety and biosecurity is necessary and urgent. Reviewing the lessons learned and regulations applied in the United States and other international frameworks helped identify potential areas for improving Brazil's ability to inventory and manage its diverse biocontainment laboratory capabilities and assure these valuable resources align with national needs and priorities.
The Brazilian government has an opportunity to revise and improve upon a national set of legislation, regulations, and policies for its high- and maximum-containment laboratories, taking advantage of legislation and guidelines published by other countries.
尽管美国和其他国家已实施全面的立法、法规和政策以支持高等级和最高等级生物安全实验室的生物安全与生物安保工作,但巴西的立法存在明显差距和不一致之处。
评估巴西在确保对高等级和最高等级生物安全实验室进行全国范围生物安全与生物安保监督及管理方面的做法。
进行了系统的差距分析,将巴西的生物安全与生物安保立法、法规和政策与其国际同行进行比较,特别关注高等级和最高等级生物安全实验室的监督及管理。
我们发现巴西的生物安全与生物安保立法、法规和政策存在相关差距。巴西高等级和最高等级生物安全实验室的管理与监管是分散的,对普遍接受的全球生物安全与生物安保合规标准的遵守程度各不相同。这些发现不仅对管理构成限制,也对巴西应对当前和未来与新发传染病相关挑战的准备工作构成限制。加强巴西关于实验室生物安全与生物安保的法律框架是必要且紧迫的。回顾美国和其他国际框架中吸取的经验教训及应用的法规,有助于确定潜在领域,以提高巴西清点和管理其多样的生物遏制实验室能力的能力,并确保这些宝贵资源符合国家需求和优先事项。
巴西政府有机会利用其他国家公布的立法和指南,修订和完善一套针对其高等级和最高等级生物安全实验室的国家立法、法规和政策。